南京招聘

职位描述：
Senior DSA in SG

ICON Clnical Research is Whole Owned Foreign Company which founded in 1990 in Ireland.

We expanded our business from 1996 in APAC region.

We set up our China office in 2005.

In China, we already own over 300 employees in our office, the Regional Director of Clinical and, Post-marketing business

In order to expand our business, the preparation and approval of country related submission packages in accordance with ICH, GCP and all applicable regulations, laws and other guidelines and ethical standards – within specific timelines and quality standards, for the review and approval of site level critical documents for Investigational Product (IP) release in accordance with regulatory/sponsor requirements – within specific timelines and quality standards, we are hiring the Study Start-Up Associate role from level I to senior. if you are with the below skills and experience, please do not hesitate to share your resume with us.
1. Bachelor or above degree in pharmacy, clinical;
2. Be with the experience in clinical study initiation or start-up review at least 1 years;
3. Knowledge on SOP, ICH-GCP;
4. Good communication ability both in English and Mandarin;
5. Site feasibility, EC submission is a plus.

Comparing with our competitors and pharmaceutical companies, we provide more flexible and reasonable working platform for coach and educate the new comer to be a professional person to concentrate on relevant industry. ICON also provides the good package and benefit to adapt the marketing development.

We more like a whole family with kind-heart and warm carefulness which you can balance your life and work here.

If you want to apply please send your resume to us directly: jerry.wang@iconplc.com and gopinath.musuvathi@iconplc.com. We are glad to respond you in time once received.

If you want to review more please visit our company website: www.iconplc.com or https://careers.iconplc.com .

Welcome to consider and join ICON. 举报 分享

We are a global provider of consulting, and outsourced development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas. ICON has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.